The Detroit News
The TheraBionic P1 device is now available for patients who have advanced liver cancer and have failed first- and second-line therapies. Boris Pasche, M.D., Ph.D., FACP, president and CEO of the Barbara Ann Karmanos Cancer Institute, chair of the Department of Oncology at Wayne State University, and co-inventor of the TheraBionic P1 device, and Anthony Shields, M.D., Ph.D., medical oncologist and member of the Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team, explained how the device works.
Read the article here.
Boris C. Pasche, M.D., Ph.D., FACP
Anthony Shields, M.D., Ph.D.